Principles and rules of circulation of medicines in the Republic of Kazakhstan

2022

Closed access Metadata (CSL-JSON)
DOI 10.54649/2077-9860-2022-4-20-30
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The presented article describes the concept, principles, rules and stages of circulation of medicines in the Republic of Kazakhstan. We are talking about the procedure for conducting a coordinated policy in the field of circulation of medicines, taking into account mutual interest in ensuring guarantees of the safety, effectiveness and quality of medicines for the life and health of people, protecting the life and health of consumers of medicines, preventing actions misleading consumers. The impact of the current legislation of the Republic of Kazakhstan in the field of health care and pharmaceutical activities on legal relations arising during the passage of all stages of circulation of medicines was considered. The main problems in this area have been disclosed. The positive experience of some foreign countries with developed legislation in the field of health care and pharmaceutical activities is being studied.